RecruitingNCT05329129

OssDsign® Spine Registry Study ("Propel")

PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE

Sponsor

OssDsign

Enrollment

450 participants

Start Date

Mar 23, 2022

Study Type

OBSERVATIONAL

Conditions

Spinal Stenosis Degenerative Disc Disease

Summary

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called OssDsign® Catalyst for people with degenerative disc disease and spinal stenosis. The study is currently recruiting participants at 15 locations. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOssDsign® Catalyst

An osteoconductive, resorbable, porous, 100 % nano synthetic calcium phosphate bone void filler

Locations(15)

Community Health Partners Neuroscience

Fresno, California, United States

Memorial Orthopaedic Surgical Group

Long Beach, California, United States

San Diego Neurosurgery

San Diego, California, United States

Orthopedic Associates of Hartford

Hartford, Connecticut, United States

Central Connecticut Neurosurgery and Spine

New Britian, Connecticut, United States

Yale Center for Clinical Investigation, Yale School of Medicine

New Haven, Connecticut, United States

Minimally Invasive Spine Center of South Florida

Miami, Florida, United States

Foundation for Orthopaedic Research and Education

Tampa, Florida, United States

Northeast Georgia Medical Center

Gainesville, Georgia, United States

Carle Foundation Hospital, NeuroScience Institute

Urbana, Illinois, United States

Orthopaedic Institute of Western Kentucky

Paducah, Kentucky, United States

OrthoBethesda Research Foundation

Bethesda, Maryland, United States

Twin Cities Orthopedics

Edina, Minnesota, United States

University Orthopedics Center

State College, Pennsylvania, United States

Texas Spine Consultants

Addison, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05329129

Related Trials

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

NCT0725480619 locations

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

NCT064384711 location

Pulse-Width Modulation

NCT061202311 location

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

NCT050379688 locations

Clinical Outcome Measure at Stryker Spine

NCT062262727 locations